TipRanks on MSN
Dynavax, Inhibikase and more: Stocks trending by analysts
Here is a breakdown of their recent ratings and the rationale behind them. Dynavax (DVAX) has abruptly shifted from a growth story to a takeout play, after Sanofi agreed to acquire the vaccine maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results